AI assistant
NEUROTECH INTERNATIONAL LIMITED — Capital/Financing Update 2021
Apr 22, 2021
65449_rns_2021-04-22_dbbd04f5-c612-49b7-a7e2-b47c433da760.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Update Summary
Entity name
NEUROTECH INTERNATIONAL LIMITED
Announcement Type
Update to previous announcement
Date of this announcement
Thursday April 22, 2021
Reason for update to a previous announcement
Application for quotation of the Shares the subject of this Appendix 3B, to satisfy the requirements under section 723(3)(a) of the Corporations Act, per the Prospectus dated 19 April 2021.
These securities are now subject to Shareholder approval, as a result the proposed issue date has now changed.
Refer to next page for full details of the announcement
Proposed issue of securities
1 / 6
Proposed issue of securities
Part 1 - Entity and announcement details
==> picture [21 x 22] intentionally omitted <==
1.1 Name of +Entity
NEUROTECH INTERNATIONAL LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
1.2 Registered Number Type
ABN
Registration Number
73610205402
1.3 ASX issuer code
NTI
1.4 The announcement is
==> picture [8 x 9] intentionally omitted <==
Update/amendment to previous announcement
1.4a Reason for update to a previous announcement
Application for quotation of the Shares the subject of this Appendix 3B, to satisfy the requirements under section 723(3)(a) of the Corporations Act, per the Prospectus dated 19 April 2021.
These securities are now subject to Shareholder approval, as a result the proposed issue date has now changed.
1.4b Date of previous announcement(s) to this update
Tuesday March 9, 2021
1.5 Date of this announcement
Thursday April 22, 2021
1.6 The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A placement or other type of issue
Proposed issue of securities
2 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 - Are any of the following approvals required for the placement or other type of issue? +Security holder approval Court approval Lodgement of court order with +ASIC ACCC approval FIRB approval Another approval/condition external to the entity Yes
7A.1a Conditions
| Approval/Condition | Date for determination | Is the date estimated or | ** Approval |
|---|---|---|---|
| +Security holder approval | Friday May 7, 2021 | actual? | received/condition met? |
| Actual | No |
Comments
Please note the issue of these securities is subject to Shareholder approval at the upcoming General Meeting scheduled for the 7th of May 2021.
Part 7B - Issue details
Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? Existing class
Details of +securities proposed to be issued
ASX +security code and description
NTI : ORDINARY FULLY PAID
Number of +securities proposed to be issued
1,000,000
Reason for the update of 'Maximum Number of +securities proposed to be issued'
Offer price details
Proposed issue of securities
3 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Are the +securities proposed to be issued being issued for a cash consideration? No
Please describe the consideration being provided for the +securities
CannaPacific to be issued 1,000,000 Shares on receipt of an Office of Drug Control permit for the production of NTI cannabis strains for clinical trials. Refer ASX Release of 9 March 2021.
Please note the issue of these securities is subject to Shareholder approval at the upcoming General Meeting scheduled for the 7th of May 2021.
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 0.063000
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? Existing class Details of +securities proposed to be issued
ASX +security code and description NTI : ORDINARY FULLY PAID Number of +securities proposed to be issued 1,000,000 Reason for the update of 'Maximum Number of +securities proposed to be issued' Offer price details Are the +securities proposed to be issued being issued for a cash consideration? No
Proposed issue of securities
4 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Please describe the consideration being provided for the +securities
CannaPacific to be issued 1,000,000 Shares within 5 business days of the delivery of the first harvest of dried flower or by 1 August 2021 whichever occurs first. Refer ASX Release of 9 March 2021.
Please note the issue of these securities is subject to Shareholder approval at the upcoming General Meeting scheduled for the 7th of May 2021.
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities
0.063000
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Part 7C - Timetable
7C.1 Proposed +issue date
Friday July 30, 2021
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? Yes
7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1
Friday May 7, 2021
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue? No
Proposed issue of securities
5 / 6
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
7E.2 Is the proposed issue to be underwritten? No
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Refer ASX Release of 9 March 2021
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No
7F.2 Any other information the entity wishes to provide about the proposed issue
Proposed issue of securities
6 / 6